Advertisement

coronary artery disease

CAD in Patients With Advanced Lung Disease

American researchers suggest that coronary artery disease not only appears to be common among patients with advanced lung disease attributable to COPD or interstitial lung disease, but also appears to be underdiagnosed. The team...

Statin Non-Adherence & Treatment Intensification

A review of more than 125,000 patients on stable statin therapy suggests that nearly half (44%) of those who had their treatment intensified were non-adherent to their treatment. When compared with adherent patients, those who...

Protecting Older, Vulnerable Patients From the Flu

People aged 65 and older account for more than 60% of the estimated 226,000 flu-related hospitalizations and 90% of the 3,000 to 49,000 flu-related deaths in the United States each year. This age group is at highest risk for...

A New Guide for Revascularizing Patients With CAD

In the December 6, 2011 Journal of the American College of Cardiology, the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) published guidelines on the management of patients undergoing...

Long-Term PCI Outcomes in Younger Adults

Italian investigators have found that both long- and short-term results in patients aged 40 and younger appear to be excellent with PCI in individuals with premature coronary artery disease. In this analysis of 214 consecutive...

Revised Guidelines for Evidence-Based PCI

Over the last decade, significant advances and innovations have rapidly evolved in the use of PCI for patients with coronary artery disease (CAD). The American College of Cardiology (ACC)/American Heart Association (AHA),...

Multivessel PCI: Coming to a Consensus

When PCI is used to treat multivessel coronary artery disease (CAD), single-vessel or multivessel interventions can be performed in one or more stages. About half of all patients with CAD have blockages in multiple arteries, and...

Drug-Eluting Stent System Gains FDA Approval

A next-generation drug-eluting stent system (PROMUS Element Plus Platinum Chromium Stent System, Boston Scientific) has received FDA approval for use in patients with coronary artery disease. The device has been shown to improve...

Loading

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage